Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

By sjmartinez • July 13, 2024

Narasaki Y, Kovesdy CP, You AS, Sumida K, Mallisetty Y, Surbhi S, Thomas F, Amin AN, Streja E, Kalantar-Zadeh K, Rhee CM. Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study. Lancet Reg Health Am. 2024 Jun 18;36:100814. doi: 10.1016/j.lana.2024.100814. PMID: 38993538; PMCID: PMC11237921.

Tags: Harbor UCLA, Nephrology, Publications, Veterans Administration

Bisphosphonate Use and Cardiovascular Outcomes According to Kidney Function Status in Post-Menopausal Women: An Emulated Target Trial from the Multi-Ethnic Study of Atherosclerosis

Ghotbi E, Subhas N, Bancks MP, Elmariah S, Halperin JL, Bluemke DA, Kestenbaum BR, Barr RG, Post WS, Budoff M, Lima JAC, Demehri S. Bisphosphonate[...]

Coronary Artery Calcium for Risk Stratification of Heart Failure Mortality: The Coronary Artery Calcium Consortium

Mhaimeed O, Dardari ZA, Khorsandi M, Dzaye O, Sharma K, Nasir K, Berman DS, Budoff MJ, Shaw LJ, Rumberger JA, Miedema MD, Blaha MJ. Coronary[...]

Oxygen dissociation curve inflection point during incremental exercise: a trigger for the Bohr effect

Burchert HH, Stringer WW, Dash RK. Oxygen dissociation curve inflection point during incremental exercise: a trigger for the Bohr effect. Pflugers Arch. 2025 Jul 10.[...]